220 related articles for article (PubMed ID: 22326673)
1. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.
Liu SH; Cheng YC
J Ethnopharmacol; 2012 Apr; 140(3):614-23. PubMed ID: 22326673
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies.
Saif MW; Lansigan F; Ruta S; Lamb L; Mezes M; Elligers K; Grant N; Jiang ZL; Liu SH; Cheng YC
Phytomedicine; 2010 Mar; 17(3-4):161-9. PubMed ID: 20092990
[TBL] [Abstract][Full Text] [Related]
3. PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.
Lam W; Jiang Z; Guan F; Huang X; Hu R; Wang J; Bussom S; Liu SH; Zhao H; Yen Y; Cheng YC
Sci Rep; 2015 Mar; 5():9384. PubMed ID: 25819872
[TBL] [Abstract][Full Text] [Related]
4. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).
Lam W; Jiang Z; Guan F; Hu R; Liu SH; Chu E; Cheng YC
BMC Complement Altern Med; 2014 Dec; 14():490. PubMed ID: 25510341
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
Kummar S; Copur MS; Rose M; Wadler S; Stephenson J; O'Rourke M; Brenckman W; Tilton R; Liu SH; Jiang Z; Su T; Cheng YC; Chu E
Clin Colorectal Cancer; 2011 Jun; 10(2):85-96. PubMed ID: 21859559
[TBL] [Abstract][Full Text] [Related]
6. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.
Wang E; Bussom S; Chen J; Quinn C; Bedognetti D; Lam W; Guan F; Jiang Z; Mark Y; Zhao Y; Stroncek DF; White J; Marincola FM; Cheng YC
BMC Med Genomics; 2011 May; 4():38. PubMed ID: 21569348
[TBL] [Abstract][Full Text] [Related]
7. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs.
Zee-Cheng RK
Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):725-36. PubMed ID: 1294861
[TBL] [Abstract][Full Text] [Related]
8. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
Lam W; Bussom S; Guan F; Jiang Z; Zhang W; Gullen EA; Liu SH; Cheng YC
Sci Transl Med; 2010 Aug; 2(45):45ra59. PubMed ID: 20720216
[TBL] [Abstract][Full Text] [Related]
9. An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.
Wang Z; Qi F; Cui Y; Zhao L; Sun X; Tang W; Cai P
Biosci Trends; 2018; 12(3):220-239. PubMed ID: 30012913
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in HL-60 cells treated with medicinal herbs.
Nishida S; Kikuichi S; Yoshioka S; Tsubaki M; Fujii Y; Matsuda H; Kubo M; Irimajiri K
Am J Chin Med; 2003; 31(4):551-62. PubMed ID: 14587878
[TBL] [Abstract][Full Text] [Related]
11. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.
Rockwell S; Grove TA; Liu Y; Cheng YC; Higgins SA; Booth CJ
Int J Radiat Biol; 2013 Jan; 89(1):16-25. PubMed ID: 22856538
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer.
Qi F; Li A; Inagaki Y; Gao J; Li J; Kokudo N; Li XK; Tang W
Biosci Trends; 2010 Dec; 4(6):297-307. PubMed ID: 21248427
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
Wang Q; Acharya N; Liu Z; Zhou X; Cromie M; Zhu J; Gao W
J Ethnopharmacol; 2018 May; 217():140-151. PubMed ID: 29458146
[TBL] [Abstract][Full Text] [Related]
14. Liquid chromatography/mass spectrometry analysis of PHY906, a Chinese medicine formulation for cancer therapy.
Ye M; Liu SH; Jiang Z; Lee Y; Tilton R; Cheng YC
Rapid Commun Mass Spectrom; 2007; 21(22):3593-607. PubMed ID: 17944003
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Evaluation of the Compatibility Effects of Huangqin Decoction on the Treatment of Irinotecan-Induced Gastrointestinal Toxicity Using Untargeted Metabolomics.
Cui DN; Wang X; Chen JQ; Lv B; Zhang P; Zhang W; Zhang ZJ; Xu FG
Front Pharmacol; 2017; 8():211. PubMed ID: 28484391
[TBL] [Abstract][Full Text] [Related]
16. Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.
Ou TT; Wu CH; Hsu JD; Chyau CC; Lee HJ; Wang CJ
J Ethnopharmacol; 2011 Apr; 135(1):162-72. PubMed ID: 21396995
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic activities of Carthami Flos and its reversal effect on multidrug resistance in cancer cells.
Wu JY; Yu ZL; Fong WF; Shi YQ
Afr J Tradit Complement Altern Med; 2013; 10(4):36-40. PubMed ID: 24146498
[TBL] [Abstract][Full Text] [Related]
18. Herbal Medicines as Adjuvants for the Treatment of Chemotherapy-Induced Diarrhea.
Zheng Z; Srinual S; Chen J; Li L; Du T; Hu M; Sun R; Gao S
Curr Drug Metab; 2023; 24(6):422-433. PubMed ID: 37592799
[TBL] [Abstract][Full Text] [Related]
19. In vitro anticancer activity of twelve Chinese medicinal herbs.
Shoemaker M; Hamilton B; Dairkee SH; Cohen I; Campbell MJ
Phytother Res; 2005 Jul; 19(7):649-51. PubMed ID: 16161030
[TBL] [Abstract][Full Text] [Related]
20. Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy.
Wang S; Wu X; Tan M; Gong J; Tan W; Bian B; Chen M; Wang Y
J Ethnopharmacol; 2012 Mar; 140(1):33-45. PubMed ID: 22265747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
